This cross-sectional study estimated the prevalence of vulvar lichen sclerosus (VLS) among adult females in the US, with subgroup analyses by age and race.
Cross-sectional design limits causal inference; specific prevalence numbers are not available in the abstract alone; potential underdiagnosis of VLS in real-world populations may affect estimates.
Clinicians should be aware that vulvar lichen sclerosus carries a measurable disease burden across US adult females, including across diverse age and racial subgroups — supporting routine screening awareness in dermatology and gynecology practice.
